Abstract

Quantitative MRI methods have recently gained extensive interest and are seeing substantial developments; however, their application in single patient vs control group comparisons is often limited by inherent statistical difficulties. One such application is detecting malformations of cortical development (MCDs) behind drug resistant epilepsies, a task that, especially when based solely on conventional MR images, may represent a serious challenge. We aimed to develop a novel straightforward voxel-wise evaluation method based on the Mahalanobis-distance, combining quantitative MRI data into a multidimensional parameter space and detecting lesion voxels as outliers. Simulations with standard multivariate Gaussian distribution and resampled DTI-eigenvalue data of 45 healthy control subjects determined the optimal critical value, cluster size threshold, and the expectable lesion detection performance through ROC-analyses. To reduce the effect of false positives emanating from registration artefacts and gyrification differences, an automatic classification method was applied, fine-tuned using a leave-one-out strategy based on diffusion and T1-weighted data of the controls. DWI processing, including thorough corrections and robust tensor fitting was performed with ExploreDTI, spatial coregistration was achieved with the DARTEL tools of SPM12. Additional to simulations, clusters of outlying diffusion profile, concordant with neuroradiological evaluation and independent calculations with the MAP07 toolbox were identified in 12 cases of a 13 patient example population with various types of MCDs. The multidimensional approach proved sufficiently sensitive in pinpointing regions of abnormal tissue microstructure using DTI data both in simulations and in the heterogeneous example population. Inherent limitations posed by registration artefacts, age-related differences, and the different or mixed pathologies limit the generalization of specificity estimation. Nevertheless, the proposed statistical method may aid the everyday examination of individual subjects, ever so more upon extending the framework with quantitative information from other modalities, e.g. susceptibility mapping, relaxometry, or perfusion.

Highlights

  • Drug resistant epilepsies (DRE)Drug resistance affects about 20–30% of the epileptic patient population, causing severely impaired quality of life and a difficult to treat situation [1, 2]

  • As false discovery rate (FDR) correction uses the p-values of each statistical test and determines the critical p for a given set, the FDR corrected D2 critical values were unique for each patient image, typically in the range between 19 and 21

  • In the simulations with standard multivariate normal distribution (SMVND) data, false positives were identified in all cases when no cluster size thresholding was employed, with both family-wise error rate (FWE) and FDR corrected critical values

Read more

Summary

Introduction

Drug resistant epilepsies (DRE)Drug resistance affects about 20–30% of the epileptic patient population, causing severely impaired quality of life and a difficult to treat situation [1, 2]. Most of the drug resistant cases (~60%) are focal epilepsies, there are generalized forms. Malformations of cortical development (MCDs) and long-term epilepsy-associated tumors (LEATs) are among the most frequent etiological factors causing DRE [3,4,5,6]. Subtypes of MCDs include focal cortical dysplasia (FCD), polymicrogyria (PMG), heterotopia (HTP), hemimegalencephaly (HME), while subtypes of LEATs include gangliogliomas, and disembryoplastic neuroepithelial tumors (DNTs) [7]. Most of these entities may exhibit variable features on MR images collected with an epilepsy protocol. Better visualization of MCDs and LEATs e.g. as shown in [9,10,11,12,13,14,15] can be crucial for improving surgical outcomes

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call